DDIT4, also known as regulated in development and DNA damage response-1 (Redd1), is highly expressed and associated with a worse prognosis in acute myeloid leukemia and solid tumors (Pinto et al., 2017). The gene discussed is DDIT4; the disease is acute myeloid leukemia.